Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria

Dihydroartemisinin-piperaquine (DHP) is an important new treatment for drug-resistant malaria, although pharmacokinetic studies on the combination are limited. In Papua, Indonesia, we assessed determinants of the therapeutic efficacy of DHP for uncomplicated malaria. Plasma piperaquine concentration...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Price, R. N., Hasugian, A. R., Ratcliff, A., Siswantoro, H., Purba, H. L. E., Kenangalem, E., Lindegardh, N., Penttinen, P., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2007
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2151469/
https://ncbi.nlm.nih.gov/pubmed/17846129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00486-07
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares